6-fluoro-5-7-dibromo-2-methyl-1-formyl-1-2-3-4-tetrahydroquinoline and Atrial-Fibrillation

6-fluoro-5-7-dibromo-2-methyl-1-formyl-1-2-3-4-tetrahydroquinoline has been researched along with Atrial-Fibrillation* in 2 studies

Other Studies

2 other study(ies) available for 6-fluoro-5-7-dibromo-2-methyl-1-formyl-1-2-3-4-tetrahydroquinoline and Atrial-Fibrillation

ArticleYear
Usefulness of Exchanged Protein Directly Activated by cAMP (Epac)1-Inhibiting Therapy for Prevention of Atrial and Ventricular Arrhythmias in Mice.
    Circulation journal : official journal of the Japanese Circulation Society, 2019, 01-25, Volume: 83, Issue:2

    It has been suggested that protein directly activated by cAMP (Epac), one of the downstream signaling molecules of β-adrenergic receptor (β-AR), may be an effective target for the treatment of arrhythmia. However, there have been no reports on the anti-arrhythmic effects or cardiac side-effects of Epac1 inhibitors in vivo. Methods and Results: In this study, the roles of Epac1 in the development of atrial and ventricular arrhythmias are examined. In addition, we examined the usefulness of CE3F4, an Epac1-selective inhibitor, in the treatment of the arrhythmias in mice. In Epac1 knockout (Epac1-KO) mice, the duration of atrial fibrillation (AF) was shorter than in wild-type mice. In calsequestrin2 knockout mice, Epac1 deficiency resulted in a reduction of ventricular arrhythmia. In both atrial and ventricular myocytes, sarcoplasmic reticulum (SR) Ca. These findings indicated that Epac1 is involved in the development of atrial and ventricular arrhythmias. CE3F4, an Epac1-selective inhibitor, prevented atrial and ventricular arrhythmias in mice.

    Topics: Animals; Atrial Fibrillation; Calcium; Cyclic AMP; Guanine Nucleotide Exchange Factors; Mice; Mice, Knockout; Quinolines; Sarcoplasmic Reticulum; Ventricular Fibrillation

2019
Exchange-protein activated by cAMP (EPAC) regulates L-type calcium channel in atrial fibrillation of heart failure model.
    European review for medical and pharmacological sciences, 2019, Volume: 23, Issue:5

    Both atrial fibrillation (AF) and heart failure (HF) are increasingly prevalent and related to high hospitalization rate and mortality. AF is a cause as well as a consequence of HF, with complicated interactions resulting in impairment of cardiac systolic and diastolic function. Conversely, the complex structural and neurohormonal alterations in HF contribute to the occurrence and development of AF. However, the molecular mechanism remains unclear. This study aims to explore the effect of Exchange-protein activated by cAMP 1 (EPAC1) on AF in isoproterenol (ISO)-induced HF and the potential molecular mechanism.. Mice and cultured isolated adult cardiomyocytes were treated with ISO and or not EPAC1 inhibitor CE3F4. Programmed electrical stimulation (PES) was performed to induce AF. EPAC1 expression was determined by Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) and Western blot. Cellular electrophysiology was examined by whole cell patch clamp.. Both mRNA and protein levels of EPAC1 were upregulated in HF mice. ISO increased the AF susceptibility, and the negative effect was deteriorated by CE3F4. ISO mediated high AF susceptibility of HF via prolonging action potential and exciting L-type calcium channel (LTCC). These could also be reversed by CE3F4 treatment.. EPAC1 increased the AF susceptibility in ISO-induced HF mouse model via alternating LTCC.

    Topics: Animals; Atrial Fibrillation; Calcium Channels, L-Type; Cells, Cultured; Disease Models, Animal; Electrophysiologic Techniques, Cardiac; Guanine Nucleotide Exchange Factors; Heart Failure; Isoproterenol; Male; Mice; Myocytes, Cardiac; Quinolines; Up-Regulation

2019